Anti-diabetic effects of 1-methylnicotinamide (MNA) in streptozocin-induced diabetes in rats. 2009

Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
Department of Hemostasis and Hemostatic Disorders, Chair of Laboratory Diagnostics, Medical University of Łódź, University Clinical Hospital No 2, Poland. cwatala@csk.umed.lodz.pl

1-Methylnicotinamide (MNA), a major endogenous metabolite of nicotinamide, possesses anti-thrombotic and anti-inflammatory activity, and reverses endothelial dysfunction. In the present work, we investigated whether such a vasoprotective profile of MNA activity affords anti-diabetic action in rats. Diabetes was induced by streptozotocin (STZ) in Sprague-Dawley rats. Eight weeks after STZ injection in untreated or MNA-treated rats (100 mg kg(-1) daily), development of diabetes (plasma concentrations of fasting and non-fasting glucose, HbA(1c), peptide C), development of oxidant stress (lipid peroxidation, carbonylation of plasma proteins), as well as NO-dependent endothelial function in aorta, coronary and mesenteric vessels were analyzed. Finally, the effect of chronic treatment with MNA on long-term survival of diabetic rats was determined. Chronic treatment with MNA profoundly lowered fasting glucose concentrations in plasma, displayed mild effects on plasma HbA(1c) and peptide C concentrations, while having no effects on non-fasting glucose. On the other hand, MNA treatment considerably lowered lipid peroxidation, protein carbonylation, completely prevented impairment of endothelium-dependent vasodilatation in the aorta that was mediated entirely by NO, but failed to affect endothelial function in resistant vessels, which was mediated only partially by NO. Most importantly, chronic treatment with MNA prolonged the long-term survival of diabetic rats. In conclusion, MNA displayed a significant anti-diabetic effect that may be linked to its vasoprotective activity.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
January 2018, Iranian journal of pharmaceutical research : IJPR,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
January 2010, Neurochemistry international,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
January 2015, PloS one,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
March 2011, Neuroscience letters,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
July 2003, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
December 1991, Diabetes,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
January 2023, International journal of ophthalmology,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
April 2010, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
November 2012, Journal of ethnopharmacology,
Cezary Watała, and Piotr Kaźmierczak, and Marcin Dobaczewski, and Tomasz Przygodzki, and Magdalena Bartuś, and Magdalena Łomnicka, and Ewa M Słomińska, and Zdena Durackova, and Stefan Chłopicki
August 1994, Ophthalmic surgery,
Copied contents to your clipboard!